Simon Wain-Hobson

This inventor holds 41 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in HIV Research. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, Invectys. Active years: 1991-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Wain-Hobson. Retrieved from https://idiyas.com/inventor/simon-wain-hobson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 41 (Patent Applications = 4)

% Patents Active = 80.5

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 110(Granted Patents)

Location History:

Montiguy le Bretonneloc, FR (1998)
Montigney Les Bretonneux, FR (1998)
Montigny les Bretonneux, FR (1991 - 2010)
Montigny le Bretonneux, FR (1991 - 2024)

Company Filing History:

Centre National De La Recherche Scientifique

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 4 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2024

Loading Chart...

Areas of Expertise:

HIV-1

Telomerase Vaccine

Cancer Vaccine

Nucleic Acid Probe

APOBEC3

Antibodies

LAV Viruses

DNA Fragments

PCR Amplification

Peptides

Diagnostic Kits

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064474 - Telomerase encoding DNA vaccine (2024-08-20),

2. 10675337 - Cancer vaccine for cats (2020-06-09),

3. 10183065 - Telomerase encoding DNA vaccine (2019-01-22),

4. 10138488 - Cancer vaccine for dogs (2018-11-27),

5. 10010591 - Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A (2018-07-03),

6. 9931387 - Cancer vaccine for cats (2018-04-03),

7. 8541206 - Differential amplification of mutant nucleic acids by PCR in a mixture of nucleic acids (2013-09-24),

8. 8507196 - Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 (2013-08-13),

9. 8329396 - Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) (2012-12-11),

10. 8288094 - APOBEC3 mediated DNA editing (2012-10-16),

11. 7767800 - [object Object] (2010-08-03),

12. 7626013 - HIV-1 DNA fragments that hybridize to genomic HIV-1DNA (2009-12-01),

13. 7585619 - Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity (2009-09-08),

14. 7351412 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA (2008-04-01),

15. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

As an assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'd be happy to help you with the article about inventor Simon Wain-Hobson.

Title: Simon Wain-Hobson: Pioneering Innovations in Molecular Biology

Introduction:

Simon Wain-Hobson, a visionary inventor in the field of molecular biology, hails from Montigny le Bretonneux, FR. With a remarkable portfolio of 35 patents, he has been at the forefront of scientific breakthroughs that have reshaped the landscape of genetic research.

Latest Patents:

1. Differential amplification of mutant nucleic acids by PCR in a mixture of nucleic acids: This patent showcases Wain-Hobson's method for enriching mutant nucleic acids in a mixture, utilizing PCR techniques to selectively amplify specific sequences.

2. Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1): This revolutionary invention focuses on detecting the presence of HIV-1 nucleic acids, aiding in the diagnosis of this critical infection.

Career Highlights:

Having worked at prestigious institutions like Institut Pasteur and Centre National De La Recherche Scientifique, Wain-Hobson has demonstrated his expertise and commitment to advancing molecular biology. His contributions have not only expanded scientific knowledge but also paved the way for innovative diagnostic tools.

Collaborations:

Throughout his career, Wain-Hobson has collaborated with esteemed peers such as Marc Alizon and Pierre Sonigo. Together, they have synergized their efforts to drive groundbreaking research in the field of genetic analysis.

Conclusion:

In conclusion, Simon Wain-Hobson emerges as a trailblazer in molecular biology, harnessing his inventive spirit to transform the way we approach genetic research. His patents and inventions reflect a dedication to excellence and a relentless pursuit of creating a brighter future through scientific innovation.

Profile summary based on public USPTO records.